Clinical Use of Iron Chelators

Repeated blood transfusions lead to the appearance of plasma non-transferrin-bound iron species (NTBI) that distribute to hepatocytes, endocrine tissues and the heart. Morbidity and mortality reflects this distribution, with heart failure remaining the leading cause of death in inadequately treated thalassaemia major (TM) patients.